Order Article Reprints

Sato S, Matsumoto H, Temmoku J, Fujita Y, Matsuoka N, Yashiro-Furuya M, Asano T, Suzuki E, Watanabe H, Kanno T, et al. Sustained Long-Term Retention Rates of Abatacept in Combination with Conventional Synthetic Disease-Modifying Antirheumatic Drugs in Elderly Patients with Rheumatoid Arthritis. Medicina. 2021; 57(9):914. https://doi.org/10.3390/medicina57090914

Sato, Shuzo, Haruki Matsumoto, Jumpei Temmoku, Yuya Fujita, Naoki Matsuoka, Makiko Yashiro-Furuya, Tomoyuki Asano, Eiji Suzuki, Hiroshi Watanabe, Takashi Kanno, and et al. 2021. "Sustained Long-Term Retention Rates of Abatacept in Combination with Conventional Synthetic Disease-Modifying Antirheumatic Drugs in Elderly Patients with Rheumatoid Arthritis" Medicina 57, no. 9: 914. https://doi.org/10.3390/medicina57090914

Sato, S., Matsumoto, H., Temmoku, J., Fujita, Y., Matsuoka, N., Yashiro-Furuya, M., Asano, T., Suzuki, E., Watanabe, H., Kanno, T., & Migita, K. (2021). Sustained Long-Term Retention Rates of Abatacept in Combination with Conventional Synthetic Disease-Modifying Antirheumatic Drugs in Elderly Patients with Rheumatoid Arthritis. Medicina, 57(9), 914. https://doi.org/10.3390/medicina57090914